Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate whether tranilast at two different dosages compared to placebo is effective in patients with active RA when added to continuing methotrexate (MTX) therapy.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Nuon Therapeutics, Inc.
NCT07233655 · Moderate to Severe Active Rheumatoid Arthritis
NCT06456489 · Active Rheumatoid Arthritis
NCT02534896 · Active Rheumatoid Arthritis
NCT04472481 · Active Rheumatoid Arthritis
NCT03599986 · Active Rheumatoid Arthritis
Mesa, Arizona
Paradise Valley, Arizona
La Jolla, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions